GridAI Technologies (GRDX) Tax Provisions (2024 - 2026)
GridAI Technologies' (GRDX) quarterly Tax Provisions came in at -$55459.0 in Q2 2026, down 101.3% quarter-over-quarter from $4.3 million in Q2 2024.
Powered by 
Analysis
GridAI Technologies (GRDX) Tax Provisions (2024 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Tax Provisions for 2 consecutive years, with -$55459.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Tax Provisions changed N/A year-over-year to -$55459.0; the trailing twelve-month figure through Jun 2026 stood at $4.2 million (up 139.6% YoY), and the FY2025 full-year result was -$398736.0, changed N/A from the prior year.
- Tax Provisions retreated to -$55459.0 in Q2 2026 per GRDX's latest filing, from $4.3 million in the prior quarter.
- Across five years, Tax Provisions topped out at $4.3 million in Q2 2024 and bottomed at -$14.9 million in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 393.00 Mn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 242.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 292.00 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 230.90 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -59.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 15.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 34.90 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -3.96 Mn |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | -55,459.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -55,459.00 |
| Jun 30, 2024 | 4.26 Mn |
| Mar 31, 2024 | -14.86 Mn |